Lessons from the niche for generation and expansion of hematopoietic stem cells

Teresa V. Bowman, Leonard I. Zon

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Hematopoietic stem cells (HSCs) are used clinically to treat human blood-related genetic diseases and leukemias, but the availability of this therapy is constrained by the limiting number of transplantable HSCs. Previous strategies to expand HSCs in vitro resulted in precocious differentiation and reduced transplant efficiency. In vivo analysis of the mechanisms utilized by fetal and adult niches to control HSCs can be mimicked for therapeutic use. This review summarizes the latest research on the in vivo HSC niche and the clinical applications of this knowledge to promote ex vivo expansion and direct de novo generation of HSCs.

Original languageEnglish (US)
Pages (from-to)135-140
Number of pages6
JournalDrug Discovery Today: Therapeutic Strategies
Volume6
Issue number4
DOIs
StatePublished - Dec 2009
Externally publishedYes

Fingerprint

Hematopoietic Stem Cells
Stem Cell Niche
Inborn Genetic Diseases
Therapeutic Uses
Leukemia
Transplants
Research

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Molecular Medicine

Cite this

Lessons from the niche for generation and expansion of hematopoietic stem cells. / Bowman, Teresa V.; Zon, Leonard I.

In: Drug Discovery Today: Therapeutic Strategies, Vol. 6, No. 4, 12.2009, p. 135-140.

Research output: Contribution to journalArticle

@article{1e406d9070e74154846eaa0ecee0f4ac,
title = "Lessons from the niche for generation and expansion of hematopoietic stem cells",
abstract = "Hematopoietic stem cells (HSCs) are used clinically to treat human blood-related genetic diseases and leukemias, but the availability of this therapy is constrained by the limiting number of transplantable HSCs. Previous strategies to expand HSCs in vitro resulted in precocious differentiation and reduced transplant efficiency. In vivo analysis of the mechanisms utilized by fetal and adult niches to control HSCs can be mimicked for therapeutic use. This review summarizes the latest research on the in vivo HSC niche and the clinical applications of this knowledge to promote ex vivo expansion and direct de novo generation of HSCs.",
author = "Bowman, {Teresa V.} and Zon, {Leonard I.}",
year = "2009",
month = "12",
doi = "10.1016/j.ddstr.2009.06.003",
language = "English (US)",
volume = "6",
pages = "135--140",
journal = "Drug Discovery Today: Therapeutic Strategies",
issn = "1740-6773",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Lessons from the niche for generation and expansion of hematopoietic stem cells

AU - Bowman, Teresa V.

AU - Zon, Leonard I.

PY - 2009/12

Y1 - 2009/12

N2 - Hematopoietic stem cells (HSCs) are used clinically to treat human blood-related genetic diseases and leukemias, but the availability of this therapy is constrained by the limiting number of transplantable HSCs. Previous strategies to expand HSCs in vitro resulted in precocious differentiation and reduced transplant efficiency. In vivo analysis of the mechanisms utilized by fetal and adult niches to control HSCs can be mimicked for therapeutic use. This review summarizes the latest research on the in vivo HSC niche and the clinical applications of this knowledge to promote ex vivo expansion and direct de novo generation of HSCs.

AB - Hematopoietic stem cells (HSCs) are used clinically to treat human blood-related genetic diseases and leukemias, but the availability of this therapy is constrained by the limiting number of transplantable HSCs. Previous strategies to expand HSCs in vitro resulted in precocious differentiation and reduced transplant efficiency. In vivo analysis of the mechanisms utilized by fetal and adult niches to control HSCs can be mimicked for therapeutic use. This review summarizes the latest research on the in vivo HSC niche and the clinical applications of this knowledge to promote ex vivo expansion and direct de novo generation of HSCs.

UR - http://www.scopus.com/inward/record.url?scp=78650304917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650304917&partnerID=8YFLogxK

U2 - 10.1016/j.ddstr.2009.06.003

DO - 10.1016/j.ddstr.2009.06.003

M3 - Article

AN - SCOPUS:78650304917

VL - 6

SP - 135

EP - 140

JO - Drug Discovery Today: Therapeutic Strategies

JF - Drug Discovery Today: Therapeutic Strategies

SN - 1740-6773

IS - 4

ER -